Statins have strong cardiovascular outcomes data. That does not mean patients with side effects should be dismissed. The better conversation is risk, targets, t…
This issue was originally published in The Longevity Letter.
Subscribe to get the full archive and new issues every Friday.
Subscribe to The Longevity LetterThe Longevity Letter
A weekly read on tests, treatment, and claims.
New issues look at what the evidence supports, what is premature, and what to skip.